“…( S )‐2,2,2‐Trifluoro‐1‐phenylethanol is used in the synthesis of several compounds for the treatment of diseases caused by activation of microglia and has, thus, attracted intense attention from the pharmaceutical industry. Therefore, 2,2,2‐trifluoroacetophenone ( 1 h ) was selected as a model substrate to test the potential of applying the EbSDR8 variant in the bioreduction of prochiral ketones.…”